Sustained release formulations of aro- matase inhibitors

Details for Australian Patent Application No. 2007263004 (hide)

Owner Novartis AG

Inventors Vucenovic, Vitomire; Lambert, Oliver; Riemenschnitter, Marc

Agent Davies Collison Cave

Pub. Number AU-A-2007263004

PCT Pub. Number WO2007/147861

Priority 60/805,508 22.06.06 US

Filing date 20 June 2007

Wipo publication date 27 December 2007

International Classifications

A61K 9/14 (2006.01) Medicinal preparations characterised by special physical form - Particulate form, e.g. powders

A61K 31/00 (2006.01)

Event Publications

8 January 2009 PCT application entered the National Phase

  PCT publication WO2007/147861 Priority application(s): WO2007/147861

28 July 2011 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(e). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2007263005-Method and device for separation and depletion of certain proteins and particles using electrophoresis

2007263000-1,2-dithiol-3-thiones as chain-transfer agents in free-radical polymerization reactions